<DOC>
	<DOCNO>NCT01580384</DOCNO>
	<brief_summary>This non-drug , longitudinal , multi-center , multi-national study evaluate suitability neurocognitive test function scale measurement cognitive functioning change individual Down Syndrome . Tests administer clinic visit Weeks 1 , ( 4 ) 24 . The duration study individual 24 27 week .</brief_summary>
	<brief_title>A Non-Drug Study The Suitability Neurocognitive Tests And Functioning Scales For The Measurement Cognitive And Functioning Changes Individuals With Down Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Down Syndrome</mesh_term>
	<criteria>Males female , 12 30 year age , diagnosis Down Syndrome Down Syndrome subject meet clinical diagnostic criterion generalize anxiety disorder , major depressive disorder , autism spectrum disorder , attention deficit hyperactivity disorder participate study provide stable medication least 8 week prior screen likely cooperate take part successfully study assessment Subjects DSMIV axis I II psychiatric disorder , except authorize inclusion criterion Subjects may able comply protocol perform outcome measure due significant hear visual impairment Subjects evidence dementia meeting clinical diagnosis dementia Subjects thyroid dysfunction diabetes adequately control stabilize treatment least 8 week prior randomization</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>30 Years</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>